The relationship between the amount of proteinuria and interstitial fibrosis/tubular atrophy in kidney transplant recipients

Document Type : Research Paper

Authors

1 Assistant Professor, Department of Nephrology, Mashhad University of Medical Sciences, Mashhad, Iran

2 Faculty Member, Islamic Azad University, Mashhad Branch, Mashhad, Iran

Abstract

Introduction: The amount of proteinuria is a predictor of renal outcome in kidney transplantation. In this study we investigated the relationship between the amount of proteinuria and interstitial fibrosis /renal atrophy (IFTA) in biopsy samples taken from kidney transplantation.
Materials and Methods: In total 60 patients with proteinuria from November 2013 to May 2017 in Montaseriyeh hospital, transplant center of Mashhad, Iran were investigated. For all patients, Biopsy of kidney transplantation was performed. Then, the relationship between proteinuria and IFTA was evaluated. 
Results: Among 60 patients 25% had nephrotic range and 75% had sub- nephrotic range proteinuria. According to the severity of fibrosis we divided the patients into three categories: mild (IFTA40). The prevalence of IFTA was mild in 57.8%, moderate in 32.8% and severe in 9.4%. According to the results of this study, there were relationships between amount of proteinuria and severity of fibrosis. Patients with nephrotic range proteinuria had more fibrosis (P<0.005).
Conclusion: Understanding the symptoms associated with fibrosis in transplanted kidney, may be useful in early diagnosis of development of fibrosis.

Keywords

References

References
 
1-       Knoll GA. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management. Am J Kidney Dis. 2009; 54(6): 1131-44.
2-       Fernández-Fresnedo G, Plaza JJ, Sánchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, Arias M.  Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant. 2004;19 Suppl 3:iii47-51.
3-       López V, Sola E, Jironda C, León M, García I, Gutierrez C, et al.  Biopsies in renal transplant patients with proteinuria: histological findings. Transplant Proc. 2011;43(6):2191-3.
4-       Roodnat JI, Mulder PG, Rischen-Vos J, van Riemsdijk IC, van Gelder T, Zietse R, et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation. 2001;72(3):438-44.
5-       Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9 Suppl 3:S1-155.
6-       Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE,et al.Banff-05meeting report: differential diagnosis of chronic allograft injury andelimination of chronic allograft nephropathy (CAN). Am J Transplant. 2007;7(3):518-26.
7-       Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M , et al: Banff 07 classification of renalallograft pathology: updates and future directions.Am J Transplant. 2008;8(4):753-60
8-       Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, et al:Proteinuria: a new marker of long-term graft and patient survival inkidney transplantation. Nephrol Dial Transplant 2004;19(Suppl 3):iii47,
9-       Amer H, Fidler ME, Myslak M, et al: Proteinuria after kidneytransplantation, relationship to allograft histologyandsurvival.Am J Transplant 2007;7:2748.
10-   Chapman JR, O’Connell PJ, Nankivell BJ. Chronic renal allograftdysfunction. J Am Soc Nephrol. 2005;16(10):3015-26
11-   Serón D, Moreso F, Ramón JM, Hueso M, Condom E, Fulladosa X , et al.Protocol renal allograftbiopsiesandthe design of clinical trials aimed to prevent or treatchronic allograft nephropathy. Transplantation. 2000;69(9):1849-55.
12-   B. H. Özdemir, A. A. Özdemir, T. Colak, S. Sezer, and M. Haberal, “The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts,” Transplantation Proceedings 2011; vol. 43, no. 2, pp. 527–529.
13-   Halimi JM, Buchler M, Al-Najjar A, Laouad I, Chatelet V, Marlière JF, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant. 2007;7(3):618-25.
14-   Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS , et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant. 2007;7(12):2748-56.
15-   Knoll GA. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management. Am J Kidney Dis. 2009;54:1131-44.
16-   Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, et al. Proteinuria after kidney transplantation relationship to allograft histology and survival. Am J Transplant. 2007;7(12):2748-56 .
17-   Vathsala A, Verani R, Schoenberg L, Lewis RM, Van Buren CT, Kerman RH, et al. Proteinuria in cyclosporinetreated renal transplant recipients. Transplantation 1990;49(1): 35–41.
18-   Yakupoglu U, Baranowska-Daca E, Rosen D, Barrios R, Suki WN, Truong LD.  Post-transplant nephrotic syndrome: A comprehensiveclinicopathologic study. Kidney Int.2004;65(6): 2360–70.
19-   Chung J, Park SK, Park JS, Kim SC, Han DJ, Yu E. Glomerulonephritisis the major cause of proteinuria in renal transplantrecipients: Histopathologic findings of renal allografts with proteinuria. Clin Transplant 2000;14(5): 499–504.
20-   Pérez Fontán M, Rodríguez-Carmona A, García Falcón T, Valdés F.  Early proteinuria in renal transplant recipients treated with cyclosporin.Transplantation 1999;67(4): 561–8.
medical journal of mashhad university of medical sciences
Volume 61, Issue 6
May and June 2019
Pages 1288-1293

Files

Share

How to cite

Statistics